Yuta Ushida
Toyota, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Robotic distal pancreatectomy with splenectomy using a novel retroperitoneal-first laparoscopic approach after Billroth I reconstruction: overcoming adhesions following gastrectomy.
Journal: Surgical oncology
Published: June 14, 2026
Optimizing indocyanine green positive staining with total liver volume-normalized dosing in robotic hepatectomy: an image-based analysis.
Journal: Journal of robotic surgery
Published: October 19, 2025
Robotic Segmentectomy 8 Using a Cranio-Ventral Approach (With Video).
Journal: Asian journal of endoscopic surgery
Published: October 04, 2025
Tumor Mutational Burden-High Intrahepatic Cholangiocarcinoma Presenting with Solitary Brain Metastasis: A Case of Precision Oncology.
Journal: Surgical case reports
Published: October 01, 2025
Hepatocolic fistula in hepatocellular carcinoma treated with atezolizumab-bevacizumab: a case report on successful salvage hepatectomy.
Journal: Journal of surgical case reports
Published: March 09, 2025
Cholangiolocarcinoma with Ductal Plate Malformation Pattern: A 6-Year Follow-Up.
Journal: Surgical case reports
Published: February 19, 2025
New Tumor Classification Using Invasion Depth in Biliary Tract Cancer Around the Cystic Duct Junction.
Journal: Annals of surgery
Published: February 17, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study.
Journal: British journal of cancer
Published: October 26, 2024
CA19-9 Reduction After 4 Months of Treatment Is a Prognostic Factor for Locally Advanced Pancreatic Cancer.
Journal: In vivo (Athens, Greece)
Published: August 01, 2022
ASO Author Reflections: What are the Indications for Conversion Surgery for Initially Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel? Is Surgery Really Worthwhile after Sufficient Chemotherapy?
Journal: Annals of surgical oncology
Published: March 02, 2022
Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study.
Journal: Annals of surgical oncology
Published: September 01, 2021
Last Updated: 09/26/2026